Skip to main content
Ocugen, Inc. logo

Ocugen, Inc. — Investor Relations & Filings

Ticker · OCGN ISIN · US43358V1098 LEI · 549300JVNUI9CXWJLR09 US Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2016-09-15 Regulatory Filings
Country US United States of America
Listing US OCGN

About Ocugen, Inc.

https://ocugen.com/

Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings
2016-09-15 English
10-Q
Interim / Quarterly Report Q2 2016
2016-08-11 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02, which relates to the "Results of Operations and Financial Condition" for the quarter ended June 30, 2016, and references a press release and a conference call. The document does not contain the full financial statements or detailed financial analysis itself but rather announces the results and provides a press release as an exhibit. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. The document is about 6810 characters, which is consistent with a typical 8-K earnings release announcement. Therefore, the correct classification is Earnings Release (ER).
2016-08-11 English
S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It includes details about the registration of additional shares under the company's 2013 Equity Incentive Plan, amendments to the plan, and related consents and powers of attorney. This type of filing is related to share issuance under employee plans and is not a financial report, earnings release, or management discussion. It is specifically a registration statement for securities issuance under an equity incentive plan, which aligns with announcements about share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so SHA is the correct category.
2016-06-30 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 22, 2016, reporting the submission of matters to a vote of security holders at the company's 2016 annual meeting. It details the voting results for director elections, ratification of the independent auditor, and approval of an equity plan amendment. The content focuses on official voting results from a shareholder meeting, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4231 characters, which is consistent with a detailed voting results announcement rather than a brief notice or proxy solicitation. Therefore, the appropriate classification is DVA.
2016-06-22 English
FORM 10-Q
Interim / Quarterly Report Q1 2016
2016-05-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.